Literature DB >> 33520995

Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs.

Yufei Xie1, Annemarie H Meijer1, Marcel J M Schaaf1.   

Abstract

Dysregulation of the inflammatory response in humans can lead to various inflammatory diseases, like asthma and rheumatoid arthritis. The innate branch of the immune system, including macrophage and neutrophil functions, plays a critical role in all inflammatory diseases. This part of the immune system is well-conserved between humans and the zebrafish, which has emerged as a powerful animal model for inflammation, because it offers the possibility to image and study inflammatory responses in vivo at the early life stages. This review focuses on different inflammation models established in zebrafish, and how they are being used for the development of novel anti-inflammatory drugs. The most commonly used model is the tail fin amputation model, in which part of the tail fin of a zebrafish larva is clipped. This model has been used to study fundamental aspects of the inflammatory response, like the role of specific signaling pathways, the migration of leukocytes, and the interaction between different immune cells, and has also been used to screen libraries of natural compounds, approved drugs, and well-characterized pathway inhibitors. In other models the inflammation is induced by chemical treatment, such as lipopolysaccharide (LPS), leukotriene B4 (LTB4), and copper, and some chemical-induced models, such as treatment with trinitrobenzene sulfonic acid (TNBS), specifically model inflammation in the gastro-intestinal tract. Two mutant zebrafish lines, carrying a mutation in the hepatocyte growth factor activator inhibitor 1a gene (hai1a) and the cdp-diacylglycerolinositol 3-phosphatidyltransferase (cdipt) gene, show an inflammatory phenotype, and they provide interesting model systems for studying inflammation. These zebrafish inflammation models are often used to study the anti-inflammatory effects of glucocorticoids, to increase our understanding of the mechanism of action of this class of drugs and to develop novel glucocorticoid drugs. In this review, an overview is provided of the available inflammation models in zebrafish, and how they are used to unravel molecular mechanisms underlying the inflammatory response and to screen for novel anti-inflammatory drugs.
Copyright © 2021 Xie, Meijer and Schaaf.

Entities:  

Keywords:  chemical-induced inflammation; drug screen; glucocorticoids; inflammatory models; mutation; tail wounding

Year:  2021        PMID: 33520995      PMCID: PMC7843790          DOI: 10.3389/fcell.2020.620984

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  9 in total

Review 1.  Real-time imaging of inflammation and its resolution: It's apparent because it's transparent.

Authors:  Tanner F Robertson; Anna Huttenlocher
Journal:  Immunol Rev       Date:  2022-01-12       Impact factor: 12.988

2.  Bacterial Quorum-Sensing Signal DSF Inhibits LPS-Induced Inflammations by Suppressing Toll-like Receptor Signaling and Preventing Lysosome-Mediated Apoptosis in Zebrafish.

Authors:  Hongjie Zhu; Zhihao Wang; Wenxin Wang; Yongbo Lu; Ya-Wen He; Jing Tian
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

3.  Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects.

Authors:  Sasja Blokzijl-Franke; Florian Piques; Maja Solman; Chuan Yan; Qiqi Yang; Marion Strullu; Sarah M Kamel; Pakize Ak; Jeroen Bakkers; David M Langenau; Hélène Cavé; Jeroen den Hertog
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

4.  An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle.

Authors:  Dhrubajyoti Nag; Dustin Farr; Saumya Raychaudhuri; Jeffrey H Withey
Journal:  iScience       Date:  2022-06-09

5.  Early inflammation dysregulates neuronal circuit formation in vivo via upregulation of IL-1β.

Authors:  Cynthia M Solek; Nasr A I Farooqi; Niklas Brake; Philip Kesner; Anne Schohl; Jack P Antel; Edward S Ruthazer
Journal:  J Neurosci       Date:  2021-06-08       Impact factor: 6.167

Review 6.  Zebrafish and Flavonoids: Adjuvants against Obesity.

Authors:  Giuseppe Montalbano; Kamel Mhalhel; Marilena Briglia; Maria Levanti; Francesco Abbate; Maria Cristina Guerrera; Enrico D'Alessandro; Rosaria Laurà; Antonino Germanà
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

Review 7.  Marine Alkaloids: Compounds with In Vivo Activity and Chemical Synthesis.

Authors:  Paulo E S Munekata; Mirian Pateiro; Carlos A Conte-Junior; Rubén Domínguez; Asad Nawaz; Noman Walayat; Elena Movilla Fierro; José M Lorenzo
Journal:  Mar Drugs       Date:  2021-06-28       Impact factor: 5.118

Review 8.  NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?

Authors:  Annabell Roberti; Laura Elizabeth Chaffey; David R Greaves
Journal:  Biology (Basel)       Date:  2022-02-26

9.  The Incoherent Fluctuation of Folate Pools and Differential Regulation of Folate Enzymes Prioritize Nucleotide Supply in the Zebrafish Model Displaying Folate Deficiency-Induced Microphthalmia and Visual Defects.

Authors:  Tsun-Hsien Hsiao; Gang-Hui Lee; Yi-Sheng Chang; Bing-Hung Chen; Tzu-Fun Fu
Journal:  Front Cell Dev Biol       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.